⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
BioTools Innovator 2026 Cohort Includes Top 30 Life Science Tools and Diagnostics Companies
businesswire.com
TMO
ABBV
DHR
ILMN
NVO
QNRX
XBIO
Emerging Hope in Multiple Myeloma Market: 7 Late-Stage Therapies Nearing the Finish Line | DelveInsight
globenewswire.com
AZN
ABBV
GILD
BMY
CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies - Persistence Market Research
prnewswire.com
AMGN
LLY
TEVA
PFE
ABBV
AbbVie Announces Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) for the Treatment of Acute Hepatitis C Infection
prnewswire.com
ABBV
AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline
prnewswire.com
ABBV
Allergan Aesthetics Receives Positive CHMP Opinion for Boey® (TrenibotulinumtoxinE) for the Temporary Improvement of Moderate to Severe Glabellar Lines in Adults USA - English USA - English USA - English USA - Français USA - Deutsch USA - español
prnewswire.com
ABBV
Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
globenewswire.com
SNGX
IPHA
BMY
NKTX
AZN
MRK
TAK
NVS
GMAB
ABBV
BIIB
CRSP
INCY
ALKS
PFE
REGN
GILD
AMGN
Late-Stage Chronic Kidney Disease Market Analysis Report 2026-2036, Profiles of Key Players - Novartis, Merck & Co, Pfizer, Sanofi, and Johnson & Johnson
globenewswire.com
AMGN
FMS
DVA
ABBV
NVS
MRK
PFE
SNY
JNJ
Laryngeal Cancer Market Research Report 2026-2036, Competitive Analysis of Major Players - Merck & Co., Pfizer, Novartis, and AbbVie
globenewswire.com
MRK
PFE
ABBV
UPSHER-SMITH LAUNCHES GENERIC VERSION OF RESTASIS® (CYCLOSPORINE OPHTHALMIC EMULSION 0.05%)
prnewswire.com
ABBV